Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

BioFlorida Conference: Here’s What You Missed

Isaac Ro, Goldman Sachs

As I mentioned last week, BIO President & CEO James C. Greenwood kicked-off  this week’s BioFlorida 14th Annual Conference with a keynote speech. Thanks to @BioFlorida2011 for tweeting some of his speech highlights. If you were not able to make it to Tampa for the conference, fear not, I’ve got you covered. Here’s a rundown of some of the things you missed: It’s All About Efficiency, Innovation and Globalization Goldman Sachs equity analyst Isaac Ro Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BioFlorida’s Conference to Focus on Latest Technologies, Access to Capital

BFAC

BIO President & CEO James C. Greenwood will commence next week’s BioFlorida 14th Annual Conference with a keynote speech at 8AM on Monday October 24, 2011 in Tampa, FL. Living up to its reputation as the premier business development, investing and networking event for Florida’s bioscience industry, more than 500 business, science and technology leaders are expected to attend the three-day conference, which runs Oct. 23-25 at the Marriot Waterside Hotel & Marina. This year’s Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

CHI Offering Free Webinar on FDA Draft Guidances

chi-logo-btn

The California Healthcare Institute will be hosting a free online discussion on Tuesday, October 25, 2011 that addresses the FDA’s recently released draft guidance documents: Draft Guidance for Industry and Food and Drug Administration Staff – Factors to Consider when Making Benefit-Risk Determinations in Medical Device Premarket Review (Aug. 15, 2011) Draft Guidance for Industry, Clinical Investigators, and Food and Drug Administration Staff – Design Considerations for Pivotal Clinical Investigations for Medical Devices (Aug. 15, 2011) Date: October Read More >

Public Policy  |  2 Comments  |  Email This Post
Tags: , ,

BayBio Announces Lifetime Achievement DiNA Award Recipient

BayBio

Dr. Michael Hunkapiller has been named BayBio’s 2011 Lifetime Achievement DiNA Award recipient. He will be honored on Thursday, November 3rd, at the 2011 Pantheon Awards Ceremony, an annual program hosted by BayBio, a life science trade association representing the industry in Northern California. From the invention of the DNA sequencer during his days at Caltech, to the introduction of first automated DNA sequencer in 1986 and the realization of the Human Genome Mapping Project Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Incentivizing Biotech Growth; States and Regions Look to Stand Out from the Crowd

map_sm_0_0

The United States’ prolonged economic woes have drastically impacted state budgets, causing across-the-board program cuts and reassessment of priorities. The bioscience industry was not immune to the crisis, but did begin to rebound much faster than many other industries. Because the biosciences remain a source of high-wage, high-skill jobs, almost every state in the country is actively engaged in building fundamental industry infrastructure. State-sponsored programs to encourage investment and help bioscience companies leverage existing resources Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,